Name: Evenity Injection
SKU: H1T172RT2L6
Price: 26456
Availability: InStock
Rating: 0 (0 reviews)

Evenity Injection

Salt Composition: Teriparatide

Manufacturer: ZYDUS CADILA

0 0 7

MRP

₹ 31,367

Price

₹ 26,456

You Save

₹ 4,911 (15%)

Status

In Stock

SKU

H1T172RT2L6

Evenity Injection contains Romosozumab, a humanized monoclonal antibody that works by stimulating bone formation while simultaneously reducing bone resorption. It belongs to a class of medications known as anti-osteoporotic agents and is primarily used to treat osteoporosis in postmenopausal women who are at high risk of fractures. By enhancing bone mineral density and strength, Evenity helps lower the risk of both vertebral and non-vertebral fractures, particularly in patients with severe osteoporosis who have not responded adequately to other treatments.

Evenity is specifically indicated for postmenopausal women who have experienced multiple fractures or are at high fracture risk due to significantly low bone mass. It is administered as a subcutaneous injection once a month for 12 months, with a standard dose of 210 mg, given as two separate injections during each monthly visit. After completing the 12-month course, patients are usually transitioned to an anti-resorptive therapy to help maintain the benefits of treatment.

While effective, Evenity may cause side effects such as joint pain, headaches, and injection site reactions. In rare cases, it may increase the risk of cardiovascular events, so it is not recommended for patients with a history of heart attack or stroke. To reduce potential side effects, it is important to follow the administration guidelines carefully. Monitoring calcium and vitamin D levels throughout treatment is also advised to avoid hypocalcemia. Reviews of Evenity highlight its success in improving bone density and reducing fractures, though the treatment can be costly. Consulting a healthcare professional is essential to weigh the benefits and potential risks based on individual health conditions.

Uses